Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

A pause in communication is typical during a new administration’s transition. But some scientists fear that tying up NIH ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...

Emil Kraepelin formulated the initial nosology of Alzheimer's disease in the first decade of the 20th century. Nowadays, clinical and pathological presentations (including those associated with ...

Cancer and its associated treatments represent a multifaceted challenge that affects both the physical and psychological well-being of patients. Over the ...

Biodexa Strengthens Management TeamAppointment of Dr Gary A. Shangold as Chief Medical OfficerBiodexa Pharmaceuticals PLC ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.